accountthe travel market. Intercell shares have lost more than half their value since the start of the year. Merck & Co (MRK.N It also had to scrap plans for a travellers' diarrhea vaccine in December after it failed in clinical trials. [ID:nLDE7270FN]...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 2-Intercell vaccine batch recalled due to problem
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account